Related Experiment Video
Updated: Oct 4, 2025

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
Published on: May 21, 2018
Targeting the Inflammasome in Cardiovascular Disease
Maria Belland Olsen1, Ida Gregersen1, Øystein Sandanger1,2
1Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway.
Abstract:
The pathogenesis of cardiovascular disease (CVD) is complex and multifactorial, and inflammation plays a central role. Inflammasomes are multimeric protein complexes that are activated in a 2-step manner in response to infection or tissue damage. Upon activation the proinflammatory cytokines, interleukins-1β and -18 are released. In the last decade, the evidence that inflammasome activation plays an important role in CVD development became stronger. We discuss the role of different inflammasomes in the pathogenesis of CVD, focusing on atherosclerosis and heart failure. This review also provides an overview of existing experimental studies and clinical trials on inflammasome inhibition as a therapeutic target in these disorders.
Related Concept Videos
Inflammation
Myocarditis I: Introduction
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Rheumatic Heart Disease I: Introduction
Coronary Artery Disease I: Introduction
The JAK-STAT Signaling Pathway

